The image represents our sensor during the process of detecting cytokine molecules being secreted from cells. Detection is a specific step in our chemical procedure. The sensor is represented by a pair of Y-shaped antibodies, the capture antibody (purple stem) and the detection antibody (pink stem); they both target the same cytokine molecule (transparent pink blob with spirals) but different epitopes. The fluorescent bead on the detection antibody is represented by a green light emitting ball. The capture antibodies are anchored in the cellular membrane represented by a layer of partially ordered white balls rendering lipid molecules. Cytokine molecules continue to be secreted from the cellular membrane and some proportion becomes captured by the sensor, while many escape from the cell. Not all capture antibodies have been able to capture the cytokines. The distant green balls with attached antibodies (pink stems) represent the nanoparticles which are yet to detect the captured cytokines.
The image represents our sensor during the process of detecting cytokine molecules being secreted from cells. Detection is a specific step in our chemical procedure. The sensor is represented by a pair of Y-shaped antibodies, the capture antibody (purple stem) and the detection antibody (pink stem); they both target the same cytokine molecule (transparent pink blob with spirals) but different epitopes. The fluorescent bead on the detection antibody is represented by a green light emitting ball. The capture antibodies are anchored in the cellular membrane represented by a layer of partially ordered white balls rendering lipid molecules. Cytokine molecules continue to be secreted from the cellular membrane and some proportion becomes captured by the sensor, while many escape from the cell. Not all capture antibodies have been able to capture the cytokines. The distant green balls with attached antibodies (pink stems) represent the nanoparticles which are yet to detect the captured cytokines.

Cell surface sensors could advance precision medicine

Embargoed until: Publicly released:

Researchers have found a way to identify multiple cell signalling proteins using a single cell rather than the billions of cells used previously. The new measurement technology, developed by researchers at the ARC Centre of Excellence for Nanoscale Biophotonics, brings precision medicine a step closer. “Cells secrete various messenger molecules, such as cytokines. They may indicate the presence of a disease or act as a driver of key therapeutic effects,” said Dr Guozhen Liu, lead author of paper detailing the technology. The method, termed OnCELISA, uses antibodies attached on specially engineered cell surfaces to capture cytokine molecules before they have a chance to disperse away from the cell.

Journal/conference: iScience

Link to research (DOI): https://doi.org/10.1016/j.isci.2019.09.019

Organisation/s: ARC Centre of Excellence for Nanoscale BioPhotonics

Funder: CNBP

Media Release

From: ARC Centre of Excellence for Nanoscale BioPhotonics

Cell surface sensors could advance precision medicine

Researchers have found a way to identify multiple cell signalling proteins using a single cell rather than the billions of cells used previously.

The new measurement technology, developed by researchers at the ARC Centre of Excellence for Nanoscale Biophotonics, brings precision medicine a step closer. “Cells secrete various messenger molecules, such as cytokines.

They may indicate the presence of a disease or act as a driver of key therapeutic effects,” says Dr Guozhen Liu, lead author of paper detailing the technology.

The method, termed OnCELISA, uses antibodies attached on specially engineered cell surfaces to capture cytokine molecules before they have a chance to disperse away from the cell.

The secreted messenger proteins such as cytokines are reported, at the single cell level, by using fluorescent magnetic nanoparticles.

Cytokines secreted from cells play a critical role in controlling many physiological functions, including immunity, inflammation, response to cancer, and tissue repair.

The OnCELISA system can be used for ultrasensitive monitoring of cytokine release by individual cells, and it can also help discover cell populations with therapeutic value.

“The ability to identify and select cell populations based on their cytokine release is particularly valuable in commercial cell technologies and it can help develop unique products, such as future non-opioid pain relief” says Dr Liu.

“Importantly, our design uses commercially available reagents only, so it can be easily reproduced by others,” she adds.

While the published work focuses on specific proinflammatory cytokines IL-6 and IL-1β, the method is potentially suitable for a broad range of other secreted proteins and cell types.

The new technique represents an advance on traditional methods such as the enzyme-linked immunosorbent assays (ELISA) that detect average levels of secreted molecules from cell ensembles.

The OnCELISA takes the ELISA approach to its absolute extreme, by detecting cytokines on the surface of individual, single live cells. The publication has been reported by prestigious iScience journal and can be found at https://www.sciencedirect.com/science/article/pii/S2589004219303578.

News for:

Australia
NSW
VIC
SA

Media contact details for this story are only visible to registered journalists.